Form 8-K - Current report:
SEC Accession No. 0000950170-24-032906
Filing Date
2024-03-18
Accepted
2024-03-18 17:02:12
Documents
11
Period of Report
2024-03-18
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K evok-20240318.htm   iXBRL 8-K 40253
  Complete submission text file 0000950170-24-032906.txt   151219

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT evok-20240318.xsd EX-101.SCH 23902
14 EXTRACTED XBRL INSTANCE DOCUMENT evok-20240318_htm.xml XML 4534
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

EIN.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36075 | Film No.: 24759906
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)